An arthritis drug has shown remarkable results in a global trial, restoring 100% of hair in some patients with severe alopecia, offering renewed hope for sufferers worldwide.
Upadacitinib is a once-daily oral medication
Aug 31, 2026
01:03 pm
What's the storyA novel treatment for alopecia areata, an autoimmune disease that causes unpredictable hair loss, has been discovered.
The condition occurs when the immune system mistakenly attacks hair follicles, leading to patchy or complete baldness.
A common arthritis drug has been found to boost hair growth in clinical trials, with over half of alopecia patients achieving…
Tests at hospitals in the US, Europe and China discover medication can help to reverse hair loss caused by the autoimmune disease.
Trials suggest more hair growth with upadacitinib in teens and adults than previously seen
Randomized trial data found hair regrowth maintained at 152 weeks
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia…
A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, researchers…
